Aslam Sohaib

Papers

1

Total Citations

2

H-Index

1

About

Aslam Sohaib is a urologic oncologist whose research focuses on refining treatment paradigms for testicular cancer, particularly seminoma. His major contribution lies in evaluating minimally invasive surgical approaches as alternatives to standard chemotherapy for clinical stage 2 seminoma. His most cited work investigates outcomes with minimally invasive retroperitoneal lymph node dissection (MI-RPLND) combined with single-dose carboplatin, offering a potential strategy to reduce the toxicity of multi-cycle chemotherapy regimens like BEP or EP. This research addresses a critical need for de-escalation of treatment in young patients with germ cell tumors. While his citation count is currently modest, his work represents an important step in personalizing therapy for stage 2 seminoma, aiming to maintain oncologic efficacy while minimizing long-term morbidity. Sohaib’s research is particularly relevant for urologists and oncologists seeking to expand the role of surgery in chemotherapy-sensitive disease, and his findings contribute to ongoing debates about optimal management of low-volume metastatic testicular cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
MP11-05 OUTCOMES WITH MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION (MI-RPLND) AND SINGLE DOSE CARBOPLATIN IN CLINICAL STAGE 2 SEMINOMA
2 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago